Story · Medicine & Biotech
NKGen Biotech to present long-term Alzheimer’s therapy follow-up at CTAD
1 outlet · first reported by Longevity.Technology 1d ago
Coverage, in order
-
1d agoNKGen Biotech to present long-term Alzheimer’s therapy follow-up at CTAD
Nkgen Biotech will present a poster at the 19th Clinical Trials on Alzheimer’s Disease conference, taking place on 16-19 November 2026, in Boston and virtually. The poster, titled Long-Term Cognitive Benefit of Troculeucel NK Cell Therapy in a Patient With Moderate Alzheimer’s Disease: A…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.